- Home
- CDTG vs LTRN Comparison
CDTG vs LTRN Comparison
Compare CDTG & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTG
- LTRN
- Stock Information
- Founded
- CDTG 2012
- LTRN 2013
- Country
- CDTG China
- LTRN United States
- Employees
- CDTG N/A
- LTRN N/A
- Industry
- CDTG
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- CDTG
- LTRN Health Care
- Exchange
- CDTG NYSE
- LTRN Nasdaq
- Market Cap
- CDTG 34.6M
- LTRN 33.7M
- IPO Year
- CDTG 2024
- LTRN 2020
- Fundamental
- Price
- CDTG $1.41
- LTRN $5.01
- Analyst Decision
- CDTG
- LTRN Hold
- Analyst Count
- CDTG 0
- LTRN 1
- Target Price
- CDTG N/A
- LTRN N/A
- AVG Volume (30 Days)
- CDTG 73.2K
- LTRN 170.5K
- Earning Date
- CDTG 04-03-2025
- LTRN 03-17-2025
- Dividend Yield
- CDTG N/A
- LTRN N/A
- EPS Growth
- CDTG N/A
- LTRN N/A
- EPS
- CDTG 0.72
- LTRN N/A
- Revenue
- CDTG $31,432,824.00
- LTRN N/A
- Revenue This Year
- CDTG N/A
- LTRN N/A
- Revenue Next Year
- CDTG N/A
- LTRN N/A
- P/E Ratio
- CDTG $1.96
- LTRN N/A
- Revenue Growth
- CDTG N/A
- LTRN N/A
- 52 Week Low
- CDTG $1.16
- LTRN $2.79
- 52 Week High
- CDTG $4.64
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- CDTG N/A
- LTRN 58.38
- Support Level
- CDTG N/A
- LTRN $4.50
- Resistance Level
- CDTG N/A
- LTRN $5.70
- Average True Range (ATR)
- CDTG 0.00
- LTRN 0.47
- MACD
- CDTG 0.00
- LTRN -0.03
- Stochastic Oscillator
- CDTG 0.00
- LTRN 49.26
About CDTG CDT ENVIRONMENTAL TECH INV HLDG LTD
CDT Environmental Technology Investment Holdings Ltd is a waste treatment company. The company generates revenue through the design, development, manufacture, sales, installation, operation and maintenance of sewage treatment systems and by providing sewage treatment services. It engages in two business lines namely, rural sewage treatment and septic tank treatment in both urban and rural areas.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.